Medicine
Lamivudine 150 mg tablet
Lamivudine 150 mg tablet is a generic prescription medicine for oral use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store LAMIVUDINE Tablets at 25°C (77°F), excursions permitted to 15° to 30°C…
Key facts
- Active ingredient (INN)
- Lamivudine
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 6 blister pack, 60 tablets, 600 tablets and 12 more
- Manufacturers
- Camber PharmaceuticalsIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaStrides PharmaIndiaApotexAmerican Health PackagingCouplerGolden State Medical SupplyIngenus PharmaceuticalsMajor Pharmaceuticals11 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store LAMIVUDINE Tablets at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF05 Lamivudine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 December 2011
- Identifiers
- RxCUI 199147, 349491DailyMed set ID 47f8be59-178c-4bad-96a4-a5c82784f308, f3637209-303e-4232-ae79-07315a990973, 2d7db3b2-9b3c-3031-e063-6294a90a342c +8NDC 50742-623, 60429-353, 67046-1459 +8Application ANDA206974, ANDA091606, ANDA090457 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-025-10 | Aurobindo PharmaIndia | 21 November 2016 |
| 60 tablet, film coated in 1 bottle | 65862-025-60 | Aurobindo PharmaIndia | 21 November 2016 |
| 600 tablet, film coated in 1 bottle | 31722-753-06 | Camber PharmaceuticalsIndia | 6 January 2014 |
| 10 tablet, film coated in 1 blister pack | 31722-753-31 | Camber PharmaceuticalsIndia | 6 January 2014 |
| 100 tablet, film coated in 1 carton | 31722-753-32 | Camber PharmaceuticalsIndia | 6 January 2014 |
| 60 tablet, film coated in 1 bottle | 31722-753-60 | Camber PharmaceuticalsIndia | 6 January 2014 |
| 60 tablet, film coated in 1 bottle | 33342-001-09 | Macleods PharmaceuticalsIndia | 2 May 2019 |
| 60 tablet, film coated in 1 bottle | 64380-710-03 | Strides PharmaIndia | 19 October 2018 |
| 60 tablet, film coated in 1 bottle | 60505-3251-6 | Apotex | 2 December 2011 |
| 1000 tablet, film coated in 1 bottle | 60505-3251-8 | Apotex | 2 December 2011 |
| 60 tablet in 1 bottle, plastic | 50742-623-60 | Ingenus Pharmaceuticals | 1 February 2017 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 60687-720-21 | American Health Packaging | 19 January 2023 |
| 30 tablet, film coated in 1 blister pack | 67046-1459-3 | Coupler | 6 February 2025 |
| 60 tablet, film coated in 1 bottle | 60429-353-60 | Golden State Medical Supply | 2 December 2011 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-6583-04 | Major Pharmaceuticals | 2 December 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Lamivudine 150 mg tablet.
Other strengths and forms of Lamivudine
Clinical summary
Lamivudine is a hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. It is available as tablets and oral solution. MedsAcross supplies Lamivudine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LamivudineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EPIVIR prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Epivir: European public assessment report (EPAR) · European Medicines Agency
- Zeffix: European public assessment report (EPAR) · European Medicines Agency
Need Lamivudine 150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.